OptimizeRx to Present at the LD 500 Virtual Investor Conference on Sept. 3, 2020

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ROCHESTER, MI / ACCESSWIRE / August 24, 2020 / OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invited to present at the LD 500 virtual institutional investor conference being held on September 1-4, 2020.

OptimizeRx CEO, William Febbo, is scheduled to present on Thursday, September 3, at 12:20 p.m. Eastern time and participate in virtual one-on-one meetings with institutional analysts and investors throughout the day.

The presentation will be webcast live and available for replay here and via the investor relations section of the company’s website at www.optimizerx.com.

Management will discuss how OptimizeRx’s growing digital point-of-care solutions have evolved into ‘must-haves’ for life science companies looking to improve essential communications with physicians and patients.

They will also discuss the company’s recent expansion of its digital health platform from ambulatory and acute care to retail pharmacy, which includes access to a new nationwide network of 10,000 FDA-cleared self-screening Smart Health Stations.

The LD 500 is one of the nation’s largest independent conferences for micro-cap companies, with over 300 names presenting. The conference will also feature variety of speakers and panelists discussing topics of interest to investors and issuers.

To schedule a virtual one-on-one meeting with OptimizeRx, you may submit your request to register for the conference here or contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events.

View OptimizeRx’s LD Micro profile here: www.ldmicro.com/profile/OPRX

Profiles powered by LD Micro and news distribution compliments of Accesswire

About OptimizeRx

OptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRx’s network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a provider’s workflow through leading electronic health platforms. OptimizeRx’s fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.

For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.

Important Cautions Regarding Forward Looking Statements

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words ‘estimate,’ ‘possible’ and ‘seeking’ and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

OptimizeRx Contact
Doug Baker, CFO
Tel (248) 651-6568 (x807)
dbaker@optimizerx.com

Media Relations Contact
Maira Alejandra, Media Relations Manager
Tel (754) 245-7070
malejandra@optimizerx.com

Investor Relations Contact
Ron Both, CMA
Tel (949) 432-7557
oprx@cma.team

SOURCE: OptimizeRx Corp.

View source version on accesswire.com:
https://www.accesswire.com/602903/OptimizeRx-to-Present-at-the-LD-500-Virtual-Investor-Conference-on-Sept-3-2020

Staff

Recent Posts

FendX Technologies Announces Fully Subscribed Closing of Non-Brokered Private Placement

Oakville, Ontario--(Newsfile Corp. - March 13, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

34 minutes ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Received FDA Clearance for the HeartBeam System – an At-Home, High-Fidelity Heart Monitoring Technology Commenced…

4 hours ago

TE Connectivity announces 9% increase in quarterly cash dividend to $0.71

Shareholders reelect all 12 members to board of directors during annual general meeting GALWAY, Ireland,…

4 hours ago

NextPlat Changes the Date of its 2024 Financial Results Report and Investor Conference Call to Monday, March 24, 2025

COCONUT GROVE, Fla., March 13, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or…

4 hours ago

Tired of Late-Night Dental Paperwork? DentScribe.ai’s New Agentic AI Let’s Dentists Focus on Patients, Not Notes

SUNNYVALE, Calif., March 13, 2025 /PRNewswire/ -- Imagine finishing your last appointment of the day and…

4 hours ago

Healthcare Sector Faces Urgent Cybersecurity Wake-Up Call; Info-Tech Research Group Releases Critical Insights for Security Leaders

In the wake of the recent Change Healthcare/UHC data breach, critical vulnerabilities in healthcare have…

4 hours ago